🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Glad to see our paper dealing with the antiplasmodial and antileukemia activity of dihydroartemisinin–HDAC inhibitor hybrids online in #mdpipharmaceuticals via MDPI. Congrats to my former master student and first author Lukas and all coauthors. mdpi.com/1535082

It is a great honor for our lab to appear on the first EFMC-branded front cover. Thank you ChemMedChem!

Very exciting days at #DPhG2022 in beautiful Marburg Philipps-Universität. I feel very honored to receive the Chemistry Europe Poster Award! Thanks to the committee for choosing my poster & thanks to my great supervisor Finn K. Hansen. Also congrats to the co-awardees Lara Toy and Marc Wolter!

When you take your eyes off the rotovap for one second

Happy to share our newest preprint dealing with HDAC inhibitors with dual-stage antiplasmodial activity. Congrats to first author Daniel Daniel Stopper and everybody involved! ChemRxiv - go.shr.lc/3JeU0ja

Thanks to everyone involved in this project!

Excited to share our new preprint on the multicomponent synthesis of quisinostat analogs as anticancer and antiplasmodial #HDAC inhibitors. Congratulations to all co-workers and collaborators, especially first author Daniel Daniel Stopper - go.shr.lc/3zbBeYu

Hydrazides Part II: Happy to share our latest preprint, which introduces the ethylhydrazide DS-103. DS-103 completely reverses cisplatin resistance. This work also includes the first alkylhydrazide:HDAC co-crystal structure ChristiansonLaboratory. Daniel Stopper go.shr.lc/3N9Xt4s

Very happy that the second paper from my PhD is out now in Eur. J. Med. Chem.! Thanks to everyone involved in this study :)

New #PROTAC preprint: In this work, we utilized a non-selective ethyl hydrazide warhead for the selective HDAC6 degradation. Congratulations to co-first authors Daniel Daniel Stopper & Irina as well as Felix Felix Feller ! go.shr.lc/4jinjC0

I am very happy that this highly collaborative work is out now in #JMedChem ACS Publications Bio & Med Chem Content Thanks to everyone involved!

The next chapter of our HDAC #PROTAC story: CRBN-recruiting PROTACs based on a non-selective ethylhydrazide #HDAC warhead induce selective HDAC6 degradation. Congrats to my PhD students Daniel Daniel Stopper & Irina (co-first authors), and Felix Felix Feller. pubs.acs.org/doi/full/10.10…